Keating Financial Advisory Services’s Avidity Biosciences RNAM Stock Holding History

Keating Financial Advisory Services’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,571	Closed	-$402K	–	2644
2025 Q4	$402K	Buy	+5,571	New	+$360K	0.05%	250

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Keating Financial Advisory Services's RNAM Position: Q1 2026 in Review

Keating Financial Advisory Services sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 5,571 shares — an estimated $402K sold.

Keating Financial Advisory Services first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $402K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Keating Financial Advisory Services reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Keating Financial Advisory Services sold 5,571 Avidity Biosciences shares in Q1 2026, an estimated $402K.
Keating Financial Advisory Services first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Keating Financial Advisory Services's Avidity Biosciences position peaked at $402K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Keating Financial Advisory Services's 13F filing for Q1 2026, filed 15 May 2026.